4d Molecular Therapeutics In shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in 4d Molecular Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including 4d Molecular Therapeutics In held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in 4d Molecular Therapeutics In by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $17M | 816k | 20.26 |
| 2023-09-30 | $2.0M | 158k | 12.73 |
| 2023-06-30 | $3.5M | 194k | 18.07 |
| 2023-03-31 | $3.4M | 198k | 17.19 |
| 2022-12-31 | $2.6M | 118k | 22.21 |
| 2022-06-30 | $933k | 134k | 6.98 |
| 2022-03-31 | $1.1M | 76k | 15.12 |
| 2021-12-31 | $734k | 34k | 21.93 |
| 2021-09-30 | $261k | 9.7k | 26.95 |
| 2021-03-31 | $542k | 13k | 43.41 |
| 2020-12-31 | $3.1M | 75k | 41.45 |